Trials / Conditions / Normal Healthy Volunteers

Normal Healthy Volunteers

12 registered clinical trials studyying Normal Healthy Volunteers.

Status	Trial	Sponsor	Phase
Completed	Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers NCT05019950	NImmune Biopharma	Phase 1
Completed	A Study Evaluating the Relative Bioavailability of Lofexidine Granules for Reconstitution Compared to LUCEMYRA NCT04188730	USWM, LLC (dba US WorldMeds)	Phase 1
Completed	Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers NCT03860571	NImmune Biopharma	Phase 1
Withdrawn	Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of NCT03291158	Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)	Phase 1
Unknown	Development and Validation of a Novel Stereoacuity Test Using Head-mounted Display NCT03234504	Yonsei University	—
Completed	Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy NCT02802631	Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)	Phase 1
Completed	Estradiol-Receptor Blockade in Older Men and Women NCT02271282	Mayo Clinic	Phase 1
Completed	Impact of Endogenous E2 on SSI and GH Rebound NCT02026973	Mayo Clinic	Phase 1
Completed	Impact of Estradiol Addback NCT01862835	Mayo Clinic	Phase 1
Completed	A Study to Evaluate the Safety, Tolerance, and Pharmacokinetic and Pharmacodynamic Profile Of 1 SR Formulation NCT01744808	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 1
Completed	Lofexidine Mass Balance in Volunteers NCT01629446	USWM, LLC (dba US WorldMeds)	Phase 1
Completed	Tolerance and Pharmacokinetics Study of MNTX Tablets NCT01366339	Bausch Health Americas, Inc.	Phase 1